Position in DGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$730,167
-$362,188 QoQ
Shares Held
3,445
-46.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#560
of 1,090 holders
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bridgefront Capital, LLC holds $4,900,467 across 7 Diagnostics & Research names. DGX ranks #4 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QGEN |
Qiagen N.V.
|
29,401 | $1,149,579 | |
| 2 | DHR |
Danaher Corp /De/
|
5,634 | $1,073,164 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
4,366 | $843,598 | |
| 4 | DGX |
Quest Diagnostics Inc
This page
|
3,445 | $730,167 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
371 | $473,956 | |
| 6 | CDNA |
CareDx, Inc.
|
11,119 | $316,891 | |
| 7 | WGS |
GeneDx Holdings Corp.
|
4,561 | $313,112 |
All Filings in DGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $730,167 | 3,445 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $1,092,355 | 6,456 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $320,280 | 2,063 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $507,551 | 3,708 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $693,261 | 5,689 | Shares | Sole | 2023-11-14 | |
| 2022-06-30 | $584,447 | 4,395 | Shares | Sole | 2022-08-12 | |
| 2020-12-31 | $462,141 | 3,878 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||